Abiopharma

Travere Therapeutics Enters Into Exclusive Licensing Agreement with Everest Medicines for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases

FORM 6-K- Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism

Gilat Presents Expanded Portfolio for Tactical Unmanned Platforms at Eurosatory 2026

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

SM Energy to Participate in Upcoming Investor Conference

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

SOLV Energy Scales Up, Now Supporting Multiple 600+ MW Solar and Battery Projects Totaling More than 4 GW Across the U.S.

Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study

X-energy Submits Xe-100 HTGR for UK Generic Design Assessment